Generative AI is swiftly shaping the healthcare sector, with McKinsey’s latest survey in December 2024 revealing that 85% of healthcare leaders across payers, health systems, and healthcare services and technology (HST) groups are either exploring or actively implementing gen AI solutions. Based on responses from 150 executives, including a significant share from organizations exceeding $10 billion in revenue, the study
The survey also indicates that healthcare organizations are increasingly quantifying the benefits of their gen AI investments, with 64% reporting anticipated or realized positive returns. Early implementations have primarily focused on enhancing administrative tasks, IT infrastructure, and clinical operations. As expertise deepens, leaders are expected to explore broader applications, including patient engagement and quality-of-care improvements. While regulatory complexities and internal capability gaps present challenges, a value-driven strategy and strong partnerships are helping organizations successfully integrate gen AI into their operations, setting a foundation for future advancements in healthcare delivery.























